Abstract
The background of this paper is the ongoing dismantling of the social insurance systems in favour of commercialisation and privatisation of insurances needed for illness, old age and premature death. This combined with the increased possibility of using genetic testing for differentiating personal insurance premiums has the potentiality of creating a ‘genetic proletariat’ — an uninsurable high-risk population. The common way of handling this problem in Sweden, and many other developed countries around the North Atlantic, has been to regulate insurance companies’ right to ask for and use genetic information in various ways. There is a distinction between partial regulation (that allows insurance companies access to genetic information from genetic tests already made, sometimes only above a specified amount, but not to demand new tests) and total regulation (that forbids insurance companies to ask for or use any genetic information). I will argue that these forms of regulation probably will have adverse consequences given the dismantling of collective social insurance systems. If this is convincing, a better way to solve the problem of an uninsurable high-risk population (and other problems) is to resurrect the collective, obligatory insurance systems in which the individual risk profile does not constitute a basis for premium determination. Both arguments cast in terms of consequences and justice render support for this conclusion.
Similar content being viewed by others
References
Brown M J (1992) ‘Evidence of Adverse Selection in the Individual Health Insurance Market’, Journal of Risk and Insurance, vol. 59.
Billings P et al (1992) ‘Discrimination as a Consequence of Genetic Testing’, American Journal of Human Genetics, vol. 50.
Chadwick R and Ngwena C (1995) ‘The Human Genome Project, Predictive Testing and Insurance Contracts: Ethical and Legal Responses’, Res Publica, Vol. 1, No. 2.
Chadwick R et al (ed. 1997), The Right to Know and the Right not to Know, Ashgate Publishing Company, Aldershot.
Chadwick R (1997) ‘The Philosophy of the Right to Know and the Right not to Know”, Chadwick R et al (ed. 1997) The Right to Know and the Right not to Know, Ashgate Publishing Company, Aldershot, chap. 1.
Daniels N (1990)‘Insurability and the HIV Epidemic: Ethical Issues in Underwriting’, The Milbank Quarterly, 68 (4).
Försäkringsavtalslag (1927:77), Nationell lagstiftning, Sverige.
Geller L N et al (1996) ‘Individual, Family, and Societal Dimensions of Genetic Discrimination: A Case Study Analysis’, Science and Engineering Ethics, 2 (1).
Göring H H et al (2001) ‘Large Upward Bias in Estimation of Locus-Specific Effect from Genomwide Scans’, American Journal of Genetics, 6.
Hedgecoe A (1996) ‘Genetic Catch-22: Testing, Risk and Private Health Insurance’, Business & Professional Ethics Journal, Vol. 15, No. 2.
Holtug N (1999) ‘Genetic Knowledge in a just Society’, Tompson A and Chadwick R (ed. 1999), Genetic Information: Acquisition, Access and Control, Kluwer Academics/Plenum Publishers, New York, chap. 27.
Johnston M (1999) ‘Selling Souls: Ethical Theory and the Commercialisation of Genetic Information’, Tompson A and Chadwick R (ed. 1999), Genetic Information: Acquisition, Access and Control, Kluwer Academics/Plenum Publishers, New York, chap
Kotlikoff L J (1996), Privatization of Social Security: How it Works and Why it Matters’, Poterba J M (ed. 1996), Tax Policy and the Economy, NBER, MIT Press, Cambridge Mass.
Kymlicka W (1995) Contemporary Political Philosophy, Oxford University Press, New York.
Lemmens T (1999) ‘Private Parties, Public Duties? The Shifting Role of Insurance Companies in the Genentic Era’, Tompson A and Chadwick R (ed. 1999), Genetic Information: Acquisition, Access and Control, Kluwer Academics/Plenum Publishers, New York, chap. 3.
Mayer N R et al (1999) ‘Coercion, Control, and Consequence in Genetic Testing: Views on Insurance among Tested Individuals and the General Public’, Tompson A and Chadwick R (ed. 1999), Genetic Information: Acquisition, Access and Control, Kluwer Academics/Plenum Publishers, New York, chap. 4.
McGleenan T (1997) ‘Rights to Know and not to Know: Is There a Need for a Genetic Privacy Law’, Chadwick R et al (ed. 1997), The Right to Know and the Right not to Know, Ashgate Publishing Company, Aldershot, chap. 5.
Munthe C (1999) Pure Selection: The Ethics of Preimplantation Genetic Diagnosis and Choosing Children Without Abortion, Acta Universitatis Gothoburgensis, Göteborg.
OECD (1998), Maintaining Prosperity in an Ageing Society, Paris.
Oppenheimer G M and Padgug R A (1991) ‘Aids and the Crisis of Health Insurance’, Reamer, F.G. (ed.) Aids and Ethics, Colombia University Press, New York, chap. 5.
Parfit D (1997) ‘Equality and Priority’, Ratio, 10 (3).
Radetzki M, Radetzki M and Juth N (2002) Att nyttja genetisk information. Hur mycket ska försäkringsbolagen få veta?, SNS förlag, Stockholm.
Rawls J (1972) A Theory of Justice, Oxford University Press, Oxford.
Rothstein M A (ed. 1998) Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era, Yale University Press, New Haven.
Sandberg P (1995) ‘Genetic Information and Life Insurance: A Proposal for an Ethical European Policy’, Social Sciences and Medicine, Vol. 40, No. 11.
Smith K R et al (1999) ‘Genetic Testing and Adverse Selection in the Market for Life Insurance’, Tompson A and Chadwick R (ed. 1999), Genetic Information: Acquisition, Access and Control, Kluwer Academics/Plenum Publishers, New York, chap. 5.
Tamburrini C M (2000) The ‘Hand of God’? Essays in the Philosophy of Sports, Acta Universitatis Gothoburgensis, Göteborg.
Tanzi V and Schuknecht L (1995), ‘The Growth of Government and the Reform of the State in Industrial Countries’, IMF WP/95/130, Washington DC.
Tompson A and Chadwick R (ed. 1999), Genetic Information: Acquisition, Access and Control, Kluwer Academics/Plenum Publishers, New York.
Wahlström J (2002) ‘Folkets oro är befogad’, Dagens nyheter, 19 Februari.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Juth, N. Insurance Companies’ Access to Genetic Information: Why Regulation Alone Is Not Enough. Monash Bioethics Review 22, 25–41 (2003). https://doi.org/10.1007/BF03351386
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351386